You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Predicted Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'CSF'
> 95% as analyzed by SDS-PAGE and HPLC.
18-19 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg- RecombinantGM-CSF,Rat [orb1494735]
> 95% as analyzed by SDS-PAGE and HPLC.
16-26 kDa, observed by non-reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg - RecombinantGM-CSF,Mouse [orb1494736]
> 95% as analyzed by SDS-PAGE and HPLC.
15~19 kDa, observed by non-reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg > 95% as analyzed by SDS-PAGE and HPLC.
22-28 kDa, observed by non-reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg- RecombinantG-CSF,Mouse [orb1494741]
> 95% as analyzed by SDS-PAGE and HPLC.
22-24 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg > 95% as analyzed by SDS-PAGE and HPLC.
18.7kDa, observed by non-reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg- RecombinantFlt-3L,Human [orb1494745]
> 95% as analyzed by SDS-PAGE and HPLC.
Multiple bands between 18~22 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg, 1 mg > 95% as analyzed by SDS-PAGE.
24-30 kDa, observed by reducing SDS-PAGE.
CHO
1 mg, 10 μg, 50 μg> 95% as analyzed by SDS-PAGE and HPLC.
Approximately 75 kDa, consisting of a 306 amino acid residue p40 subunit and a 197 amino acid residue p35 subunit.
HEK 293
5 μg, 25 μg, 1 mg> 95% as analyzed by SDS-PAGE and HPLC.
25~28 kDa, observed by reducing SDS-PAGE.
HEK 293
10 μg, 50 μg, 1 mg